TWST
Twist Bioscience CorpNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$3.09B
P/E Ratio
—
EPS
$-1.27
Beta
2.21
52W High
$57.88
52W Low
$23.30
50-Day MA
$47.62
200-Day MA
$35.90
Dividend Yield
—
Profit Margin
-19.60%
Forward P/E
—
PEG Ratio
—
About Twist Bioscience Corp
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $391.56M |
| Gross Profit (TTM) | $202.13M |
| EBITDA | $-112.75M |
| Operating Margin | -31.70% |
| Return on Equity | -16.80% |
| Return on Assets | -13.50% |
| Revenue/Share (TTM) | $6.50 |
| Book Value | $7.44 |
| Price-to-Book | 6.77 |
| Price-to-Sales (TTM) | 7.89 |
| EV/Revenue | 7.63 |
| EV/EBITDA | -35.26 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 16.90% |
| Shares Outstanding | $61.31M |
| Float | $54.65M |
| % Insiders | 1.52% |
| % Institutions | 122.54% |
Historical Volatility
HV 10-Day
67.66%
HV 20-Day
73.17%
HV 30-Day
70.73%
HV 60-Day
67.85%
HV Rank
69.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($50.89 target)
1
Strong Buy7
Buy2
HoldData last updated: 4/14/2026